http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S61197515-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-336
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C50-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C43-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C313-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215
filingDate 1985-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3eaafe0efd705d343862da9736629c13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00c7c97a7f3713c38ba6f27098b3941e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5c09a63e2dd914d7616c1a80b5e03f7
publicationDate 1986-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S61197515-A
titleOfInvention Antiasthmatic agent
abstract PURPOSE: To provide an antiasthmatic agent containing a specific 1,4- benzoquinone derivative, having 5-lipoxigenase-inhibiting action, and useful for the prevention and remedy of various diseases caused by the formation of SRS-A. n CONSTITUTION: The objective agent contains the compound of formula I {R 1 and R 3 are alkyl, alkoxy, amino, etc.; R 2 is H, halogen, alkyl, etc.; A and D are alkylene; B is CH=CH, group of formula II, C≡C, etc.; when m is 1, lis 0 or 1, and when m is 0, l is also 0; E is group of formula III [R 4 and R 6 are R 1 ; R 5 is R 2 , G-C≡C-R 8 (G is alkylene; R 8 is alkyl), etc.], or group of formula IV (R 7 is H or methyl)}, or formula V (R 11 is OH or alkoxy; R 12 is H or R 12 ; R 13 is H or alkyl; M is alkylene; Q is CH=CH, group of formula II, C≡C or CH 2 -CH 2 ) as an active component. The compound has cerebral and cardiac circulation improving activity and cerebral ischemia-preventive activity as well, and is useful also as an agent for activating cardiac and cerebral metabolism, remedy for cardiac insufficiency and cardiac and cerebral circulation improving agent. n COPYRIGHT: (C)1986,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9957214-B2
priorityDate 1985-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S60156610-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0452253-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408144

Total number of triples: 36.